VIDEO: Dupilumab and adjuvant tacrolimus improves severity of AD, new study shows
- Jeremy Visser
- Apr 28, 2022
- 1 min read
According to a new study, patients with atopic dermatitis (AD) are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus as opposed to dupilumab alone.
Kommentare